Payments to Acquire Property, Plant, and Equipment of Akebia Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Akebia Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Akebia Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $18,000.
  • Akebia Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $291,000, a 782% increase from 2024.
  • Akebia Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $33,000.
  • Akebia Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $0, a 100% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Akebia Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $291,000 +$258,000 +782% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $33,000 +$33,000 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $0 -$114,000 -100% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $114,000 +$55,000 +93% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $59,000 -$258,000 -81% 01 Jan 2021 31 Dec 2021 10-K/A 28 Aug 2023 2022 FY
2020 $317,000 -$6,338,000 -95% 01 Jan 2020 31 Dec 2020 10-K/A 28 Aug 2023 2022 FY
2019 $6,655,000 +$5,049,000 +314% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $1,606,000 -$16,000 -0.99% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,622,000 -$1,040,000 -39% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $2,662,000 +$2,248,000 +543% 01 Jan 2016 31 Dec 2016 10-K 26 Mar 2019 2018 FY
2015 $414,000 +$185,000 +81% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $229,000 +$210,000 +1105% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017 2016 FY
2013 $19,000 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY

Akebia Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $18,000 +$18,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $0 -$114,000 -100% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q1 2022 $114,000 +$55,000 +93% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $59,000 +$59,000 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $0 -$1,928,000 -100% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $1,928,000 +$1,632,000 +551% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $296,000 -$131,000 -31% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $427,000 +$318,000 +292% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $109,000 -$91,000 -46% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $200,000 +$58,000 +41% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $142,000 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.